Mairs & Power Inc’s Rockwell Medical RMTI Stock Holding History

Mairs & Power Inc’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-182	Closed	-$55K	–	226
2019 Q3	$55K	Buy	+182	New	+$55.9K	﹤0.01%	210

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mairs & Power Inc's RMTI Position: Q4 2019 in Review

Mairs & Power Inc sold out of Rockwell Medical (RMTI) in Q4 2019, closing a stake of 182 shares — an estimated $55K sold.

Mairs & Power Inc first reported a position in RMTI in Q3 2019 and held it in 1 quarter. The position peaked at $55K in Q3 2019. 83 funds tracked by Wall St. Rank hold RMTI as of Q4 2019.

Mairs & Power Inc reported no remaining Rockwell Medical position as of Q4 2019 after selling out during the quarter.
Mairs & Power Inc sold 182 Rockwell Medical shares in Q4 2019, an estimated $55K.
Mairs & Power Inc first reported a position in Rockwell Medical in Q3 2019 and held it in 1 quarter.
Mairs & Power Inc's Rockwell Medical position peaked at $55K in Q3 2019.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2019.

Based on Mairs & Power Inc's 13F filing for Q4 2019, filed 14 Feb 2020.